JPH0193554A - Organic compound - Google Patents
Organic compoundInfo
- Publication number
- JPH0193554A JPH0193554A JP63200334A JP20033488A JPH0193554A JP H0193554 A JPH0193554 A JP H0193554A JP 63200334 A JP63200334 A JP 63200334A JP 20033488 A JP20033488 A JP 20033488A JP H0193554 A JPH0193554 A JP H0193554A
- Authority
- JP
- Japan
- Prior art keywords
- formula
- dimethoxy
- compound expressed
- acid
- reaction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000002894 organic compounds Chemical class 0.000 title 1
- 125000002252 acyl group Chemical group 0.000 claims abstract description 13
- 150000001875 compounds Chemical class 0.000 abstract description 32
- 238000006243 chemical reaction Methods 0.000 abstract description 22
- 239000003054 catalyst Substances 0.000 abstract description 11
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 abstract description 10
- 125000000217 alkyl group Chemical group 0.000 abstract description 10
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium on carbon Substances [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 abstract description 5
- USHAGKDGDHPEEY-UHFFFAOYSA-L potassium persulfate Chemical compound [K+].[K+].[O-]S(=O)(=O)OOS([O-])(=O)=O USHAGKDGDHPEEY-UHFFFAOYSA-L 0.000 abstract description 3
- 239000002841 Lewis acid Substances 0.000 abstract description 2
- 239000003814 drug Substances 0.000 abstract description 2
- 150000007517 lewis acids Chemical class 0.000 abstract description 2
- 210000002460 smooth muscle Anatomy 0.000 abstract description 2
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 239000003158 myorelaxant agent Substances 0.000 abstract 1
- 230000001737 promoting effect Effects 0.000 abstract 1
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 33
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 25
- 239000002904 solvent Substances 0.000 description 22
- 239000000243 solution Substances 0.000 description 21
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 12
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 12
- 239000013078 crystal Substances 0.000 description 12
- -1 phenylacetyl groups Chemical group 0.000 description 12
- 238000003756 stirring Methods 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical group O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 9
- 229910052739 hydrogen Inorganic materials 0.000 description 9
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 8
- 239000001257 hydrogen Substances 0.000 description 8
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 8
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 7
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 6
- 238000010531 catalytic reduction reaction Methods 0.000 description 6
- 238000000921 elemental analysis Methods 0.000 description 6
- 238000002844 melting Methods 0.000 description 6
- 230000008018 melting Effects 0.000 description 6
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 5
- UKVIEHSSVKSQBA-UHFFFAOYSA-N methane;palladium Chemical compound C.[Pd] UKVIEHSSVKSQBA-UHFFFAOYSA-N 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- 239000012230 colorless oil Substances 0.000 description 4
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 4
- 239000000706 filtrate Substances 0.000 description 4
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 4
- 229910052757 nitrogen Inorganic materials 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- QGJOPFRUJISHPQ-UHFFFAOYSA-N Carbon disulfide Chemical compound S=C=S QGJOPFRUJISHPQ-UHFFFAOYSA-N 0.000 description 3
- 238000005727 Friedel-Crafts reaction Methods 0.000 description 3
- 229910021578 Iron(III) chloride Inorganic materials 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 125000004432 carbon atom Chemical group C* 0.000 description 3
- 150000002431 hydrogen Chemical class 0.000 description 3
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 238000006722 reduction reaction Methods 0.000 description 3
- YFRFHMUSYMUXAV-UHFFFAOYSA-N 2-(20-hydroxyicosyl)-5,6-dimethoxy-3-methylphenol Chemical compound COC1=CC(C)=C(CCCCCCCCCCCCCCCCCCCCO)C(O)=C1OC YFRFHMUSYMUXAV-UHFFFAOYSA-N 0.000 description 2
- KRVZVBUKLVSUDM-UHFFFAOYSA-N 2-[5-(20-acetyloxyicosyl)-4-(carboxymethyl)-1,4-dihydroxy-2,3-dimethoxy-6-methylcyclohexa-2,5-dien-1-yl]acetic acid Chemical compound COC1=C(OC)C(O)(CC(O)=O)C(CCCCCCCCCCCCCCCCCCCCOC(C)=O)=C(C)C1(O)CC(O)=O KRVZVBUKLVSUDM-UHFFFAOYSA-N 0.000 description 2
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 108091027881 NEAT1 Proteins 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 208000026062 Tissue disease Diseases 0.000 description 2
- RCNHNKNQMYQQMY-UHFFFAOYSA-N [11-(2-hydroxy-3,4-dimethoxy-6-methylphenyl)-11-oxoundecyl] acetate Chemical compound COC1=CC(C)=C(C(=O)CCCCCCCCCCOC(C)=O)C(O)=C1OC RCNHNKNQMYQQMY-UHFFFAOYSA-N 0.000 description 2
- 235000011054 acetic acid Nutrition 0.000 description 2
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 2
- WTEOIRVLGSZEPR-UHFFFAOYSA-N boron trifluoride Chemical compound FB(F)F WTEOIRVLGSZEPR-UHFFFAOYSA-N 0.000 description 2
- 210000005013 brain tissue Anatomy 0.000 description 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 125000004063 butyryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 150000001244 carboxylic acid anhydrides Chemical class 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- ZKQFHRVKCYFVCN-UHFFFAOYSA-N ethoxyethane;hexane Chemical compound CCOCC.CCCCCC ZKQFHRVKCYFVCN-UHFFFAOYSA-N 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 235000019253 formic acid Nutrition 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000002107 myocardial effect Effects 0.000 description 2
- LQNUZADURLCDLV-UHFFFAOYSA-N nitrobenzene Chemical compound [O-][N+](=O)C1=CC=CC=C1 LQNUZADURLCDLV-UHFFFAOYSA-N 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 229910052763 palladium Inorganic materials 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 235000019260 propionic acid Nutrition 0.000 description 2
- 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- 229910052703 rhodium Inorganic materials 0.000 description 2
- 239000010948 rhodium Substances 0.000 description 2
- MHOVAHRLVXNVSD-UHFFFAOYSA-N rhodium atom Chemical compound [Rh] MHOVAHRLVXNVSD-UHFFFAOYSA-N 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- 230000000451 tissue damage Effects 0.000 description 2
- 231100000827 tissue damage Toxicity 0.000 description 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 2
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 2
- BQXNPGQTNJWQJG-UHFFFAOYSA-N (20-chloro-20-oxoicosyl) acetate Chemical compound C(C)(=O)OCCCCCCCCCCCCCCCCCCCC(=O)Cl BQXNPGQTNJWQJG-UHFFFAOYSA-N 0.000 description 1
- UKDOTCFNLHHKOF-FGRDZWBJSA-N (z)-1-chloroprop-1-ene;(z)-1,2-dichloroethene Chemical group C\C=C/Cl.Cl\C=C/Cl UKDOTCFNLHHKOF-FGRDZWBJSA-N 0.000 description 1
- LAIYHJLJHGPSMA-UHFFFAOYSA-N 11-(2,5-dihydroxy-3,4-dimethoxy-6-methylphenyl)undecyl acetate Chemical compound COC1=C(O)C(C)=C(CCCCCCCCCCCOC(C)=O)C(O)=C1OC LAIYHJLJHGPSMA-UHFFFAOYSA-N 0.000 description 1
- VTVIVMHHJLFDGV-UHFFFAOYSA-N 11-(2-hydroxy-3,4-dimethoxy-6-methylphenyl)undecyl acetate Chemical compound COC1=CC(C)=C(CCCCCCCCCCCOC(C)=O)C(O)=C1OC VTVIVMHHJLFDGV-UHFFFAOYSA-N 0.000 description 1
- SOOWXRNIQPDZDQ-UHFFFAOYSA-N 11-hydroxy-1-(2-hydroxy-3,4-dimethoxy-6-methylphenyl)undecan-1-one Chemical compound COC1=CC(C)=C(C(=O)CCCCCCCCCCO)C(O)=C1OC SOOWXRNIQPDZDQ-UHFFFAOYSA-N 0.000 description 1
- HEZKISZUXFUMGR-UHFFFAOYSA-N 12-(2-hydroxy-3,4-dimethoxy-6-methylphenyl)dodecyl acetate Chemical compound COC1=CC(C)=C(CCCCCCCCCCCCOC(C)=O)C(O)=C1OC HEZKISZUXFUMGR-UHFFFAOYSA-N 0.000 description 1
- SHRZCDBVLADXKH-UHFFFAOYSA-N 12-hydroxy-1-(2-hydroxy-3,4-dimethoxy-6-methylphenyl)dodecan-1-one Chemical compound COC1=CC(C)=C(C(=O)CCCCCCCCCCCO)C(O)=C1OC SHRZCDBVLADXKH-UHFFFAOYSA-N 0.000 description 1
- VMHWZDULLBLUMS-UHFFFAOYSA-N 2-(12-hydroxydodecyl)-5,6-dimethoxy-3-methylcyclohexa-2,5-diene-1,4-dione Chemical compound COC1=C(OC)C(=O)C(CCCCCCCCCCCCO)=C(C)C1=O VMHWZDULLBLUMS-UHFFFAOYSA-N 0.000 description 1
- RRWRVESUJNAFJF-UHFFFAOYSA-N 2-(20-hydroxyicosyl)-5,6-dimethoxy-3-methylbenzene-1,4-diol Chemical compound COC1=C(O)C(C)=C(CCCCCCCCCCCCCCCCCCCCO)C(O)=C1OC RRWRVESUJNAFJF-UHFFFAOYSA-N 0.000 description 1
- MSLWQFCMYSRFMS-UHFFFAOYSA-N 2-(20-hydroxyicosyl)-5,6-dimethoxy-3-methylcyclohexa-2,5-diene-1,4-dione Chemical compound COC1=C(OC)C(=O)C(CCCCCCCCCCCCCCCCCCCCO)=C(C)C1=O MSLWQFCMYSRFMS-UHFFFAOYSA-N 0.000 description 1
- 229910015900 BF3 Inorganic materials 0.000 description 1
- 206010007559 Cardiac failure congestive Diseases 0.000 description 1
- 229910021591 Copper(I) chloride Inorganic materials 0.000 description 1
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- VCUFZILGIRCDQQ-KRWDZBQOSA-N N-[[(5S)-2-oxo-3-(2-oxo-3H-1,3-benzoxazol-6-yl)-1,3-oxazolidin-5-yl]methyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C1O[C@H](CN1C1=CC2=C(NC(O2)=O)C=C1)CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F VCUFZILGIRCDQQ-KRWDZBQOSA-N 0.000 description 1
- CYTYCFOTNPOANT-UHFFFAOYSA-N Perchloroethylene Chemical group ClC(Cl)=C(Cl)Cl CYTYCFOTNPOANT-UHFFFAOYSA-N 0.000 description 1
- 239000007868 Raney catalyst Substances 0.000 description 1
- NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 description 1
- 229910000564 Raney nickel Inorganic materials 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 229910021627 Tin(IV) chloride Inorganic materials 0.000 description 1
- 150000001242 acetic acid derivatives Chemical class 0.000 description 1
- 150000008065 acid anhydrides Chemical class 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000007933 aliphatic carboxylic acids Chemical class 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 150000001649 bromium compounds Chemical class 0.000 description 1
- 125000001246 bromo group Chemical group Br* 0.000 description 1
- HXTLWOZJMYIANK-UHFFFAOYSA-N butyl acetate;methanol Chemical compound OC.CCCCOC(C)=O HXTLWOZJMYIANK-UHFFFAOYSA-N 0.000 description 1
- 230000003727 cerebral blood flow Effects 0.000 description 1
- 150000001805 chlorine compounds Chemical class 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- OXBLHERUFWYNTN-UHFFFAOYSA-M copper(I) chloride Chemical compound [Cu]Cl OXBLHERUFWYNTN-UHFFFAOYSA-M 0.000 description 1
- 229940045803 cuprous chloride Drugs 0.000 description 1
- NPOMSUOUAZCMBL-UHFFFAOYSA-N dichloromethane;ethoxyethane Chemical compound ClCCl.CCOCC NPOMSUOUAZCMBL-UHFFFAOYSA-N 0.000 description 1
- DENRZWYUOJLTMF-UHFFFAOYSA-N diethyl sulfate Chemical compound CCOS(=O)(=O)OCC DENRZWYUOJLTMF-UHFFFAOYSA-N 0.000 description 1
- 229940008406 diethyl sulfate Drugs 0.000 description 1
- VAYGXNSJCAHWJZ-UHFFFAOYSA-N dimethyl sulfate Chemical compound COS(=O)(=O)OC VAYGXNSJCAHWJZ-UHFFFAOYSA-N 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 230000003308 immunostimulating effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 125000002346 iodo group Chemical group I* 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- OTCKOJUMXQWKQG-UHFFFAOYSA-L magnesium bromide Chemical compound [Mg+2].[Br-].[Br-] OTCKOJUMXQWKQG-UHFFFAOYSA-L 0.000 description 1
- 229910001623 magnesium bromide Inorganic materials 0.000 description 1
- 229910001510 metal chloride Inorganic materials 0.000 description 1
- RPNNPZHFJPXFQS-UHFFFAOYSA-N methane;rhodium Chemical compound C.[Rh] RPNNPZHFJPXFQS-UHFFFAOYSA-N 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
- MCSAJNNLRCFZED-UHFFFAOYSA-N nitroethane Chemical compound CC[N+]([O-])=O MCSAJNNLRCFZED-UHFFFAOYSA-N 0.000 description 1
- LYGJENNIWJXYER-UHFFFAOYSA-N nitromethane Chemical compound C[N+]([O-])=O LYGJENNIWJXYER-UHFFFAOYSA-N 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- MUMZUERVLWJKNR-UHFFFAOYSA-N oxoplatinum Chemical compound [Pt]=O MUMZUERVLWJKNR-UHFFFAOYSA-N 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 150000004968 peroxymonosulfuric acids Chemical class 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 229910003446 platinum oxide Inorganic materials 0.000 description 1
- 229920000137 polyphosphoric acid Polymers 0.000 description 1
- OTYBMLCTZGSZBG-UHFFFAOYSA-L potassium sulfate Chemical compound [K+].[K+].[O-]S([O-])(=O)=O OTYBMLCTZGSZBG-UHFFFAOYSA-L 0.000 description 1
- 229910052939 potassium sulfate Inorganic materials 0.000 description 1
- 235000011151 potassium sulphates Nutrition 0.000 description 1
- WYVAMUWZEOHJOQ-UHFFFAOYSA-N propionic anhydride Chemical compound CCC(=O)OC(=O)CC WYVAMUWZEOHJOQ-UHFFFAOYSA-N 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- PUGUQINMNYINPK-UHFFFAOYSA-N tert-butyl 4-(2-chloroacetyl)piperazine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCN(C(=O)CCl)CC1 PUGUQINMNYINPK-UHFFFAOYSA-N 0.000 description 1
- 229950011008 tetrachloroethylene Drugs 0.000 description 1
- HPGGPRDJHPYFRM-UHFFFAOYSA-J tin(iv) chloride Chemical compound Cl[Sn](Cl)(Cl)Cl HPGGPRDJHPYFRM-UHFFFAOYSA-J 0.000 description 1
- XJDNKRIXUMDJCW-UHFFFAOYSA-J titanium tetrachloride Chemical compound Cl[Ti](Cl)(Cl)Cl XJDNKRIXUMDJCW-UHFFFAOYSA-J 0.000 description 1
- IECKAVQTURBPON-UHFFFAOYSA-N trimethoxymethylbenzene Chemical compound COC(OC)(OC)C1=CC=CC=C1 IECKAVQTURBPON-UHFFFAOYSA-N 0.000 description 1
- TZPKFPYZCMHDHL-UHFFFAOYSA-N trimethoxytoluene Natural products COC1=CC(OC)=C(C)C(OC)=C1 TZPKFPYZCMHDHL-UHFFFAOYSA-N 0.000 description 1
- 239000011592 zinc chloride Substances 0.000 description 1
- 235000005074 zinc chloride Nutrition 0.000 description 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
【発明の詳細な説明】
本発明は一般式
(式中nは11−22の整数、R1は低級アルキル基、
RIRl、R4は同一もしくは異なって水素、低級アル
キル基もしくは低級アシル基を示す)
で表わされる化合物に関する。Detailed Description of the Invention The present invention is based on the general formula (where n is an integer of 11-22, R1 is a lower alkyl group,
RIRl and R4 are the same or different and represent hydrogen, a lower alkyl group, or a lower acyl group.
本発者うは2,3−ジアルコキシ−5−メチルフェノー
ルの誘導体について多年の研究を重ねた結果、本発明を
完成するに至った。As a result of many years of research into derivatives of 2,3-dialkoxy-5-methylphenol, the present inventor has completed the present invention.
前記の式中、R1、R2、R5またはR4で示される低
級アルキル基は、たとえばメチル、エチル、プロピルも
しくはブチル基であり、その炭素数は一般に4以下が好
ましい。R2* R1またはR4で示される低級アシル
基は炭素数が1−8のものが挙げられ、その例としては
ホルミル、アセチル、プロピオニル、ブチリル基のよう
な脂肪族アシル基、フェニルアセチル基のような芳香脂
肪族アシル基またはベンゾイル基のような芳香族アシル
基が挙げられる。In the above formula, the lower alkyl group represented by R1, R2, R5 or R4 is, for example, a methyl, ethyl, propyl or butyl group, and the number of carbon atoms thereof is generally preferably 4 or less. R2* The lower acyl group represented by R1 or R4 includes those having 1 to 8 carbon atoms, examples of which include aliphatic acyl groups such as formyl, acetyl, propionyl, and butyryl groups, and phenylacetyl groups. Examples include aromatic acyl groups such as araliphatic acyl groups or benzoyl groups.
上記−数式(1)の化合物はたとえばつぎのようにして
製造することができる。The compound of formula (1) above can be produced, for example, as follows.
まず一般式
0Rs
(式中、各記号は前記と同意義である。)で表わされる
化合物と一般式
(式中、nは前記と同意義であり、Yは水素、低級アル
キル基または低級アシル基を、2はハロゲン原子を示す
。)で表わされる化合物を反応させて一般式
(式中、各記号は前記と同意義である。)で表わされる
化合物を得、これを還元して一般式(式中、各記号は前
記と同意義である。)で表わされる化合物を得、ついで
これを酸化することにより、一般式(1)中、Rs +
14が水素である化合物すなわち一般式
(式中、各記号は前記と同意義である。)で表わされる
化合物を製造することができる。First, a compound represented by the general formula 0Rs (in the formula, each symbol has the same meaning as above) and the general formula (in the formula, n has the same meaning as above, and Y is hydrogen, a lower alkyl group, or a lower acyl group) , 2 represents a halogen atom) to obtain a compound represented by the general formula (in the formula, each symbol has the same meaning as above), and this is reduced to form the general formula ( In the general formula (1), Rs +
A compound in which 14 is hydrogen, that is, a compound represented by the general formula (in the formula, each symbol has the same meaning as above) can be produced.
一般式(1)中、R4,R4が低級アシル基である化合
物すなわち一般式
(式中、几1.R2は前記と同意義であり、病。A compound in which R4 and R4 are lower acyl groups in the general formula (1), that is, a compound having the general formula (wherein 几1.R2 has the same meaning as above;
R′4 は低紀アシル基を示す。)で表わされる化合物
は化合物(1−1)にカルボン酸無水物を反応させるこ
とにより製造することができる。R'4 represents a lower acyl group. The compound represented by ) can be produced by reacting compound (1-1) with a carboxylic acid anhydride.
一般式(I)中、R5,几4 が低級アルキル基である
化合物すなわち一般式
(式中、几1.R2は前記と同意義であり、W3゜R4
は低級アルキル基を示す。)で表わされる化合物は、化
合物(I−1) にジ低級アルキル硫酸を反応させる
ことにより製造することができる。Compounds in which R5 and R4 are lower alkyl groups in the general formula (I), that is, compounds of the general formula (wherein R1.R2 have the same meanings as above, and W3゜R4
represents a lower alkyl group. ) can be produced by reacting compound (I-1) with di-lower alkyl sulfuric acid.
上記の一般式(I[)において、Yで示される低級アル
キル基は、たとえばメチル、エチル、プロピルもしくは
ブチル基で、その炭素数は一般に4以下が好ましい。ま
た、Yで示される低級アシル基の例は、アセチル、プロ
ピオニル、ブチリル基のヨウナ脂肪族アシル基、フェニ
ルアセチル基のような芳香脂肪族アシル基、またはベン
ゾイル基のような芳香族アシルなど炭素数1−8のもの
が挙げられる。2のハロゲンはクロル、ブロムまたはヨ
ードでもよい。In the above general formula (I[), the lower alkyl group represented by Y is, for example, a methyl, ethyl, propyl or butyl group, and the number of carbon atoms thereof is generally preferably 4 or less. Examples of lower acyl groups represented by Y include acetyl, propionyl, butyryl groups, aromatic aliphatic acyl groups such as phenylacetyl groups, and aromatic acyl groups such as benzoyl groups. 1-8 are mentioned. The halogen at 2 may be chloro, bromo or iodo.
化合物(If)と化合物(III)の反応は一般にフリ
ーデル・クラフト反応の条件で行われる。反応は触媒の
存在下に行うのが好ましく、触媒はフリーデル・クラフ
ト反応に用いうるものならばいずれでもよい。好ましい
触媒の例は、硫酸、リン酸、ポリリン酸などの鉱酸;塩
化アルミニウム、塩化亜鉛、塩化第二スズ、四塩化チタ
ン、塩化第一銅、臭化アルミニウム、臭化マグネシウム
などの金属塩化物や臭化物;三フッ化ホウ素その他のル
イス酸である。The reaction between compound (If) and compound (III) is generally carried out under Friedel-Crafts reaction conditions. The reaction is preferably carried out in the presence of a catalyst, and any catalyst that can be used in Friedel-Crafts reactions may be used. Examples of preferred catalysts are mineral acids such as sulfuric acid, phosphoric acid, polyphosphoric acid; metal chlorides such as aluminum chloride, zinc chloride, stannic chloride, titanium tetrachloride, cuprous chloride, aluminum bromide, magnesium bromide, etc. and bromides; boron trifluoride and other Lewis acids.
反応は上記の触媒の存在下に通常溶媒を用いて行われる
が、無溶媒で行うこともできる。The reaction is usually carried out in the presence of the above-mentioned catalyst using a solvent, but it can also be carried out without a solvent.
溶媒としてはフリーデル・クラフト反応に使用される溶
媒をいずれも用いうる。好ましい溶媒は、タトエハニト
ロベンゼン、ニトロメタン、ニトロエタンなどのニトロ
基を有する溶媒;ジクロルメタン、クロロホルム、四塩
化炭素、1,2−ジクロルエタン、1.2−ジクロルエ
チレン、1,1,2゜2−テトラクロルエタン、1,1
,2.2−テトラクロルエチレンなどのハロゲン化炭化
水素型溶媒;エーテル、テトラヒドロフラン、1.2−
ジメトキシエタンなどのエーテル型溶媒、二硫化炭素で
ある。As the solvent, any solvent used in Friedel-Crafts reactions can be used. Preferred solvents include solvents having a nitro group such as nitrobenzene, nitromethane, and nitroethane; dichloromethane, chloroform, carbon tetrachloride, 1,2-dichloroethane, 1,2-dichloroethylene, 1,1,2゜2-tetra Chlorethane, 1,1
, 2.2-Halogenated hydrocarbon type solvents such as tetrachloroethylene; ether, tetrahydrofuran, 1.2-
Ether type solvents such as dimethoxyethane, carbon disulfide.
反応は溶媒を使用しない場合は、通常的−10゜ないし
250℃の温度範囲で、溶媒を使用する場合は、通常−
10℃ないしその溶媒の沸点付近の温度で行われる。When a solvent is not used, the reaction is usually carried out at a temperature range of -10° to 250°C, and when a solvent is used, the reaction is usually carried out at a temperature range of -10° to 250°C.
It is carried out at a temperature of 10° C. or around the boiling point of the solvent.
化合物(IV)の還元反応にはンC=0基を>OH2基
に変換できる反応であればいずれも用いうるが、とりわ
け接触還元が有利である。接触還元における触媒の好ま
しい例は、パラジウム−カーボン(好ましくは1−20
%のパラジウムを含有)、ラネーニッケル、酸化白金、
ロジウム−カーボン(好ましくは1−20%のロジウム
を含有)、あるいは白金、パラジウム、ロジウムなどの
塩化物から得られるウィルキンソン氏錯体である。For the reduction reaction of compound (IV), any reaction that can convert a C=0 group into a >OH2 group can be used, but catalytic reduction is particularly advantageous. A preferred example of a catalyst in catalytic reduction is palladium-carbon (preferably 1-20
% palladium), Raney nickel, platinum oxide,
Wilkinson complexes obtained from rhodium-carbon (preferably containing 1-20% rhodium) or chlorides of platinum, palladium, rhodium, etc.
本還元反応は適当な溶媒の存在下に行うのが好ましい。This reduction reaction is preferably carried out in the presence of a suitable solvent.
その溶媒は所望の還元反応を阻害しないものであればい
ずれでもよい。好ましい溶媒の例は、酢酸エチル、酢酸
ブチルなどの酢酸エステル;メタノール、エタノール、
ブタノールなどの低級アルコール、酢酸、ギ酸、プロピ
オン酸などの低級脂肪族カルボン酸である。Any solvent may be used as long as it does not inhibit the desired reduction reaction. Examples of preferred solvents are acetate esters such as ethyl acetate, butyl acetate; methanol, ethanol,
These are lower alcohols such as butanol, and lower aliphatic carboxylic acids such as acetic acid, formic acid, and propionic acid.
本反応は少量、たとえば1−10%、の反応促進剤(た
とえば、塩酸、過塩素酸、p−トルエンスルホン酸など
)の存在下に行うのが有利である。The reaction is advantageously carried out in the presence of a small amount, for example 1-10%, of a reaction promoter (eg hydrochloric acid, perchloric acid, p-toluenesulfonic acid, etc.).
反応温度は好ましくはO’−150℃の範囲から選択さ
れるが、一般には反応は室温で行われる。The reaction temperature is preferably selected from the range O'-150°C, but generally the reaction is carried out at room temperature.
反応に使用する水素の圧力は1気圧から150気圧の範
囲で選択してもよいが、通常は1気圧が便宜に用いられ
る。The pressure of hydrogen used in the reaction may be selected within the range of 1 atm to 150 atm, but 1 atm is usually conveniently used.
化合物(1)の酸化は化合物(7)にたとえば過硫酸カ
リウムを反応させることによって行うことができる。Oxidation of compound (1) can be carried out by reacting compound (7) with, for example, potassium persulfate.
化合物(1−1’)を化合物(1−2)に導びく反応に
おいて用いられるカルボン酸無水物とじてはたとえば酢
酸無水物、プロピオン酸無水物などの他たとえば蟻酸と
酢酸、プロピオン酸などとの混合酸無水物があげられる
。Examples of carboxylic anhydrides used in the reaction for leading compound (1-1') to compound (1-2) include acetic anhydride, propionic anhydride, and the like, as well as formic acid and acetic acid, propionic acid, etc. Examples include mixed acid anhydrides.
化合物(I−2)を化合物(1−3)に導びく反応にお
いて用いられるジ低級アルキル硫酸としては、たとえば
ジメチル硫酸、ジエチル硫酸などがあげられる。Examples of the di-lower alkyl sulfuric acid used in the reaction for leading compound (I-2) to compound (1-3) include dimethyl sulfate and diethyl sulfate.
本発明の化合物(I)は新規である。それは生理的生体
抵抗性制御作用なかんずく免疫促進作用を、さらには平
滑筋弛緩作用を示し、たとえば人間を含む動物の生理的
生体抵抗制御作用、とりわけ免疫アジュバントとして使
用される。また、化合物(1)は医薬などの合成中間体
としても有用である。Compound (I) of the present invention is new. It exhibits physiological bioresistance controlling effects, particularly immunostimulating effects, and smooth muscle relaxing effects, and is used, for example, in physiological bioresistance controlling effects in animals including humans, particularly as an immune adjuvant. Compound (1) is also useful as a synthetic intermediate for pharmaceuticals and the like.
たとえば化合物(I)を常法により酸化反応して付すこ
とにより心筋組織障害および脳組織障碍の改善作用を有
する一般式
〔式中各記号は前記と同意義である〕で表わされる化合
物に導びくことができる。化合物(I[)および(V)
は心筋組織障害および脳組織障碍の改善に有用であり、
たとえば人間を含む動物の虚血性およびうっ血性心不全
、脳血流障碍における酸素賦活に効果がある。For example, by subjecting compound (I) to an oxidation reaction using a conventional method, a compound represented by the general formula [in the formula, each symbol has the same meaning as above], which has an effect of improving myocardial tissue damage and brain tissue damage, is obtained. be able to. Compounds (I[) and (V)
is useful for improving myocardial tissue disorders and brain tissue disorders,
For example, it is effective in oxygen activation in ischemic and congestive heart failure and cerebral blood flow disorders in animals including humans.
参考例1
11−アセトキシ−n−ウンデシル酸クロリド(27,
69)の1.2−ジクロルエタン溶液(150ml)に
塩化アルミニウム(28g)を加え、室温で2時間かき
混ぜる。本反応液を5℃に冷却し、これに3.4.5−
トリメトキシトルエン(19,19)の1.2−ジクロ
ルエタン溶液(50ml ) を加え1.室温で72時
間かき混ぜる。Reference example 1 11-acetoxy-n-undecylic acid chloride (27,
Add aluminum chloride (28 g) to a 1,2-dichloroethane solution (150 ml) of 69) and stir at room temperature for 2 hours. This reaction solution was cooled to 5°C and added to 3.4.5-
Add a solution of trimethoxytoluene (19,19) in 1,2-dichloroethane (50 ml) and 1. Stir at room temperature for 72 hours.
ついで反応液を50°−60℃に加熱し、さらに30分
間かき混ぜる。放冷後反応液に氷水300m1 を加え
生成物をジクロルメタンで抽出する。The reaction mixture is then heated to 50°-60°C and stirred for an additional 30 minutes. After cooling, 300 ml of ice water was added to the reaction solution, and the product was extracted with dichloromethane.
ジクロルメタン層14水洗し、無水硫酸マグネシウムで
乾燥後、溶媒を留去すると淡黄色油状物として6−(1
1−アセトキシ−1−オキソウンデシル)−2、5−ジ
メトキシ−5−メチルフェノール(35f ’)が得ら
れる。Dichloromethane layer 14 was washed with water, dried over anhydrous magnesium sulfate, and the solvent was distilled off to give 6-(1
1-acetoxy-1-oxoundecyl)-2,5-dimethoxy-5-methylphenol (35f') is obtained.
IRνNeatcm ’:1730(OAc)、IEi
80ax
(CO)、1610.1580(Ar)MSm/e:3
94(M+)、352,334゜6−(11−アセトキ
シ−1−オキソウンデシル)−2,3−ジメトキシ−5
−メチルフェノール(34f)のメタノール溶液(30
0rl)に水酸化ナトリウム(7y)を加え、室温で2
時間かき混ぜる。反応液に5N塩酸を加え中和した後、
溶媒を留去すると粗結晶が得られる。氷晶を水洗し、つ
いでエーテル−ヘキサン(1:1)から再結晶すると無
色針状晶の6−(11−ヒドロキシ−1−オキソウンデ
シル)−2,3−ジメトキシ−5−メチルフェノール(
30g)が得うれる。IRνNeatcm': 1730 (OAc), IEi
80ax (CO), 1610.1580 (Ar) MSm/e: 3
94(M+), 352,334°6-(11-acetoxy-1-oxoundecyl)-2,3-dimethoxy-5
- Methylphenol (34f) methanol solution (30
Add sodium hydroxide (7y) to
Stir for an hour. After neutralizing the reaction solution by adding 5N hydrochloric acid,
When the solvent is distilled off, crude crystals are obtained. The ice crystals were washed with water and then recrystallized from ether-hexane (1:1) to yield colorless needle-like crystals of 6-(11-hydroxy-1-oxoundecyl)-2,3-dimethoxy-5-methylphenol (
30g) can be obtained.
融点81℃
元素分析 C20HII205として
計算値 C,68,15:H,9,15実験値 0.6
8.47 ;H,9,30KBr + 。Melting point 81℃ Elemental analysis Calculated value as C20HII205 C,68,15:H,9,15 Experimental value 0.6
8.47; H, 9,30KBr + .
エル箋axCm 、3500(OH)、3300(
OH)。L paper axCm, 3500 (OH), 3300 (
OH).
11370.1660(00)、1610.1580(
Ar)
NMRδCD” :1.2−1.9[16H,m。11370.1660(00), 1610.1580(
Ar) NMRδCD”: 1.2-1.9 [16H, m.
99m
−(CHz)s−)、2.41(3H,s 、C5−a
H,)。99m-(CHz)s-), 2.41(3H,s, C5-a
H,).
2.86(2H,t 、J=7Hz 、02−H2)
、3.60(2H、t 、J=6Hz 、−CH20H
)、3.83(3H,s、OCHg)、18G(3H,
S 、00H3)。2.86 (2H,t, J=7Hz, 02-H2)
, 3.60 (2H, t, J=6Hz, -CH20H
), 3.83 (3H, s, OCHg), 18G (3H,
S, 00H3).
6.26(IH,S 、C4−H)、9.92(1H,
s 。6.26 (IH, S, C4-H), 9.92 (1H,
s.
0、−OH)
M8 m/e:352(M+)、334,195゜6
−(11−ヒドロキシ−1−オキソウンデシル)−2,
3−ジメトキシ−5−メチルフェノール(14g)の酢
酸溶液(200ml )に5%パラジウム−炭素(50
%含水物)(3g)と70%過塩素酸(0,1m1)を
加え、常温、常圧で接触還元する。水素の吸収が終了し
たら、触媒をろ別し、ろ液を減圧下に濃縮する。残留物
をジクロルメタンで抽出し、ジクロルメタン層は5%炭
酸水素ナトリウム水溶液で洗浄後、無水硫酸マグネシウ
ムで乾燥する。溶媒を留去すると無色油状物トシて6−
(11−アセトキシウンデシル)−2゜3−ジメトキシ
−5−メチルフェノール(15g)が得られる。0, -OH) M8 m/e: 352 (M+), 334,195゜6
-(11-hydroxy-1-oxoundecyl)-2,
A solution of 3-dimethoxy-5-methylphenol (14 g) in acetic acid (200 ml) was mixed with 5% palladium-carbon (50
% hydrate) (3 g) and 70% perchloric acid (0.1 ml) were added, and catalytic reduction was carried out at room temperature and pressure. After hydrogen absorption is completed, the catalyst is filtered off and the filtrate is concentrated under reduced pressure. The residue is extracted with dichloromethane, and the dichloromethane layer is washed with a 5% aqueous sodium bicarbonate solution and then dried over anhydrous magnesium sulfate. When the solvent was distilled off, a colorless oil was left.
(11-acetoxyundecyl)-2°3-dimethoxy-5-methylphenol (15 g) is obtained.
Neat
IR’maxCm−’:3450(OH) 、 173
0(OAc)。Neat IR'maxCm-': 3450 (OH), 173
0 (OAc).
1610.1580(Ar)。1610.1580 (Ar).
NMRaCDCls: 1.1−1.9 〔181i、
m、 −(CH2)9pm
−)、2.C2(3u、s、oAc)、2.22(3H
。NMRaCDCls: 1.1-1.9 [181i,
m, -(CH2)9pm-), 2. C2 (3u, s, oAc), 2.22 (3H
.
s 、C5−CH5)、 2.54(2H,t 、J=
7Hz 。s, C5-CH5), 2.54 (2H,t, J=
7Hz.
a+’、−42)、3.79(3H,S、ocH,)、
3.83(3H,s、0CHs)、4.01(2H,t
、J=6Hz 、−CH2・0AC) 、 5.78
(1H,S 、0l−OH) 、 6.23 (IH、
s 、 04−H)。a+', -42), 3.79 (3H, S, ocH,),
3.83 (3H, s, 0CHs), 4.01 (2H, t
, J=6Hz, -CH2・0AC), 5.78
(1H,S,0l-OH), 6.23 (IH,
s, 04-H).
MSm/e :380(M )、338,181実施
例1
6−(11−アセトキシウンデシル)−2,3−ジメト
キシ−5−メチルフェノール(0,6y )のテトラヒ
ドロフラン溶液(70ml )に過硫酸力lJウム(2
,Of )(7)水溶液(20ml ) ヲ加、t、室
温、窒素気流下に42時間がき混ぜる。生成物をすばや
くエーテルで抽出し、エーテル層は窒素気流下に水洗し
、無水硫酸マグネシウムで乾燥後エーテルを留去すると
無色油状物として6−(11−アセトキシウンデシル)
−2,3−ジメトキシ−5−メチルヒドロキノン(0,
431)カ得うれる。MSm/e: 380 (M), 338,181 Example 1 Add persulfuric acid to a tetrahydrofuran solution (70 ml) of 6-(11-acetoxyundecyl)-2,3-dimethoxy-5-methylphenol (0,6y). lJum(2
, Of ) (7) Aqueous solution (20 ml) and stir for 42 hours at room temperature under a nitrogen stream. The product was quickly extracted with ether, the ether layer was washed with water under a nitrogen stream, dried over anhydrous magnesium sulfate, and the ether was distilled off to give 6-(11-acetoxyundecyl) as a colorless oil.
-2,3-dimethoxy-5-methylhydroquinone (0,
431) I am happy.
Neat −+。Neat -+.
エルνmax cm 、3450(OH)、17
30(OAc)、1620 (Ar)
−:] 、2.02(31(、S 、0AC)、2.1
4(3H。L νmax cm, 3450 (OH), 17
30 (OAc), 1620 (Ar) -:], 2.02 (31 (,S, 0AC), 2.1
4 (3H.
s 、C5−CHり、2.59 (2H、t 、J=7
Hz 。s, C5-CH, 2.59 (2H, t, J=7
Hz.
(1−H2)、3.86 (6H、S 、0cH3X2
)。(1-H2), 3.86 (6H, S, 0cH3X2
).
4.03 (2H、t 、J=6Hz 、CHtOAc
)。4.03 (2H, t, J=6Hz, CHtOAc
).
5.23(IH,S、OH)、5.27(IH,S、O
H)M8m/e : 396(M+)、354.33
6 。5.23 (IH, S, OH), 5.27 (IH, S, O
H) M8m/e: 396 (M+), 354.33
6.
参考例2
6−(11−アセトキシウンデシル)−2,3−ジメト
キシ−5−メチルヒドロキノンをメタノール性塩化第二
鉄で、ついで参考例1の該工程にならいメタノール性濃
塩酸で処理すると6−(11−ヒドロキシウンデシル)
−2,3−ジメトキシ−5−メチル−1,4−ジベンゾ
キノンが得られる。Reference Example 2 When 6-(11-acetoxyundecyl)-2,3-dimethoxy-5-methylhydroquinone is treated with methanolic ferric chloride and then with methanolic concentrated hydrochloric acid following the steps in Reference Example 1, 6- (11-hydroxyundecyl)
-2,3-dimethoxy-5-methyl-1,4-dibenzoquinone is obtained.
参考例3
12−アセトキシ−n−ドデシル酸クロリド(8,5i
(7)1.2−ジクロルエタン溶液(30ml ’)
に塩化アルミニウム(8,211)を加え室温で2時
間かきまぜる。本反応液を5℃に冷却し、これに3.4
.5−トリメトキシトルエン(5,6y)の1.2−ジ
クロルエタン溶液(20ml)を加え、室温で72時間
かき混ぜる。ついで反応液を5o−so℃に加熱し30
分間かき混ぜる。Reference example 3 12-acetoxy-n-dodecylic acid chloride (8,5i
(7) 1,2-dichloroethane solution (30ml')
Add aluminum chloride (8,211) to the mixture and stir at room temperature for 2 hours. This reaction solution was cooled to 5°C, and 3.4
.. A solution of 5-trimethoxytoluene (5,6y) in 1,2-dichloroethane (20 ml) was added, and the mixture was stirred at room temperature for 72 hours. The reaction solution was then heated to 5o-so℃ for 30
Stir for a minute.
反応液にメタノール(200ml ) を加え3時間5
0℃でかき混ぜる。溶媒を留去し、残留物をジクロルメ
タンで抽出する。ジクロルメタン層は水洗し、無水硫酸
マグネシウムで乾燥後、溶媒を留去すると粗結晶が得ら
れる。水晶をエーテル−ヘキサン(1:1)から再結晶
すると無色針状晶の6−(12−ヒドロキシ−1−オキ
ソドデシル)−2,3−ジメトキシ−5−メチルフェノ
ール(8,59)が得られる。融点82℃
元素分析 C’l I H5405として計算値 C,
68,82;H,9,35実験値 0.69.00;H
,9,46KBr −1゜
IRν cm 、3500(OH)、3200aX
(OH)、1670(C!O)、1610.1580(
Ar)
NMRδCD”’ :1.1−1.9(18H,m。Add methanol (200 ml) to the reaction solution and leave for 3 hours 5
Stir at 0°C. The solvent is distilled off and the residue is extracted with dichloromethane. The dichloromethane layer is washed with water, dried over anhydrous magnesium sulfate, and the solvent is distilled off to obtain crude crystals. Recrystallization of the crystals from ether-hexane (1:1) yields colorless needle-like crystals of 6-(12-hydroxy-1-oxododecyl)-2,3-dimethoxy-5-methylphenol (8,59). . Melting point 82℃ Elemental analysis C'l I Calculated value as H5405 C,
68,82;H,9,35 Experimental value 0.69.00;H
, 9,46KBr -1゜IRν cm , 3500 (OH), 3200aX (OH), 1670 (C!O), 1610.1580 (
Ar) NMRδCD'': 1.1-1.9 (18H, m.
pm
−(CH)9−〕、2.41(3H9S、C5−CH5
)。pm -(CH)9-], 2.41 (3H9S, C5-CH5
).
2.84(2H,t 、J=7Hz 、C2−H2)
、3.59(2H,t 、J=6Hz 、−0H20H
)、3.83(3H,s 、0CHs)、3.86(5
H,s 、0CHs)。2.84 (2H, t, J=7Hz, C2-H2)
, 3.59 (2H,t, J=6Hz, -0H20H
), 3.83 (3H,s, 0CHs), 3.86 (5
H,s,0CHs).
6.26(IEI、S、04−H)、9.92(IH,
S。6.26 (IEI, S, 04-H), 9.92 (IH,
S.
cl−oH)。cl-oH).
MBm/l: 366(M+)、348.1856−
(12−ヒドロキシ−1−オキソドデシル)−2,3−
ジメトキシ−5−メチルフェノール(6,4y )の酢
酸溶液(1sorl)に、5%パラジウム−炭素(50
%含水物) (1,19)と70%過塩素酸(0,1m
l ) を加え、常温、常圧で接触還元する。水素の吸
収が終了したら、触媒を濾別し、濾液を減圧下に濃縮す
る。残留物をジクロルメタンで抽出する。ジクロルメタ
ン層は5%炭酸水素ナトリウム水溶液で洗浄後、無水硫
酸マグネシウムで乾燥する。溶媒を留去すると無色油状
物として13−(12−アセトキシドデシル)−2,3
−ジメトキシ−5−メチルフェノール(6,89)が得
られる。MBm/l: 366 (M+), 348.1856-
(12-hydroxy-1-oxododecyl)-2,3-
5% palladium-carbon (50
% water content) (1,19) and 70% perchloric acid (0,1 m
l) and catalytic reduction at room temperature and pressure. When the absorption of hydrogen has ended, the catalyst is filtered off and the filtrate is concentrated under reduced pressure. The residue is extracted with dichloromethane. The dichloromethane layer is washed with a 5% aqueous sodium bicarbonate solution and then dried over anhydrous magnesium sulfate. When the solvent was distilled off, 13-(12-acetoxydodecyl)-2,3 was obtained as a colorless oil.
-dimethoxy-5-methylphenol (6,89) is obtained.
Neat −1。Neat -1.
IRvmax cm 、3450(OH)、1730
(OAC)。IRvmax cm, 3450 (OH), 1730
(OAC).
1610 、1580 (Ar)
NMR弓罠′S: 1.1−1.8 (20H、m 、
−(OH2)、。1610, 1580 (Ar) NMR bow trap'S: 1.1-1.8 (20H, m,
-(OH2),.
−) 、 2.02 (3H,8,0Ac) 、 2.
23 (3H。-), 2.02 (3H,8,0Ac), 2.
23 (3H.
S 、05−CH5)、 2.55 (2H、t 、
J=7Hz。S, 05-CH5), 2.55 (2H, t,
J=7Hz.
C1−Hz)、3.79−(3H,S、0OHa)、1
83(3H,S 、0CHx)、4.02(2H,t
、J= 8Hz * OH20A c ) 、5.78
(I H、s + C+ −OH)。C1-Hz), 3.79-(3H,S,0OHa), 1
83 (3H, S, 0CHx), 4.02 (2H, t
, J=8Hz * OH20A c ), 5.78
(I H, s + C+ -OH).
8.23(IH,s、04−H)
MSm/e:394(M )、352,334゜実施
例2
6−(12−アセトキシドデシル)−2,3−ジメトキ
シ−5−メチルフェノール(0,7y )のテトラヒド
ロフラン溶液(80ml ’)に過硫酸カリウム(2,
5F/ )の水溶液(20ml )を加え、室温、窒素
気流下に48時間かき混ぜる。生成物をエーテルですば
やく抽出し、エーテルを留去する。残留物に無水酢酸5
mlを加え2時間放置する。過剰の無水酢酸を留去し残
留物をエーテルで抽出する。エーテルを水洗し、無水硫
酸ナトリウムで乾燥後エーテルを留去すると無色油状物
として6−(12−アセトキシドデシル)2.3−ジメ
トキシ−5−メチルヒドロキノン−1,4−ジアセター
)(0,61g)が得られる。8.23 (IH, s, 04-H) MSm/e: 394 (M ), 352,334° Example 2 6-(12-acetoxydodecyl)-2,3-dimethoxy-5-methylphenol (0, Potassium persulfate (2,
Add an aqueous solution (20 ml) of 5 F/ ) and stir at room temperature under a nitrogen stream for 48 hours. The product is quickly extracted with ether and the ether is distilled off. Acetic anhydride 5 to the residue
Add ml and leave for 2 hours. Excess acetic anhydride is distilled off and the residue is extracted with ether. The ether was washed with water, dried over anhydrous sodium sulfate, and then distilled off to give 6-(12-acetoxydodecyl)2,3-dimethoxy-5-methylhydroquinone-1,4-diaceter (0.61 g) as a colorless oil. is obtained.
Neat −1。Neat -1.
1几v Cm 、 178 G 、 1765
、1735ax
(OAc)、1620.1570(Ar)。1 liter v Cm, 178 G, 1765
, 1735ax (OAc), 1620.1570 (Ar).
−:] 、2.02(3H,8,0Ac)、2.06
(3H。-: ] , 2.02 (3H, 8,0Ac), 2.06
(3H.
8.06−CH5)、2J2(6H,S 、0AcX2
)。8.06-CH5), 2J2(6H,S, 0AcX2
).
2.46(2H,t 、J=7Hz 、0l−Ht)、
3.81(6H,S 、00H3X2)、4.05 (
2H,t 、J=6Hz 、 CH20Ac)。2.46 (2H, t, J=7Hz, 0l-Ht),
3.81 (6H, S, 00H3X2), 4.05 (
2H,t, J=6Hz, CH20Ac).
MSm/e :494(M )、452,410゜
279.197゜
参考例4
6−(12−アセトキシドデシル)−2,3−ジメトキ
シ−5−メチルヒドロキシ−1,4−ジアセタートを参
考例1中の該当する工程にならい、メタノール性塩化第
二鉄で処理すると6−(12−ヒドロキシドデシル)−
2、3−ジメトキシ−5−メチル−1,4−ベンゾキノ
ンが得られる。MSm/e: 494 (M), 452,410°279.197° Reference Example 4 6-(12-acetoxydodecyl)-2,3-dimethoxy-5-methylhydroxy-1,4-diacetate in Reference Example 1 When treated with methanolic ferric chloride following the corresponding process, 6-(12-hydroxydodecyl)-
2,3-dimethoxy-5-methyl-1,4-benzoquinone is obtained.
MSm/e:450(M )、452(M +2)。MSm/e: 450 (M), 452 (M +2).
330.332,197,196,195゜参考例5
20−アセトキシ−n−エイコサン酸クロリド(16F
)の1,2−ジクロルエタン溶液(60ml )に塩化
アルミニウム(11y)を加え、室温で2時間かき混ぜ
る。ついで本反応液を5℃に冷却し、これに3.4.5
−トリメトキシトルエン(7,49)の1.2−ジクロ
ルエタン溶液(2oml)を加え、室温で72時間かき
混ぜる。330.332,197,196,195° Reference Example 5 20-acetoxy-n-eicosanoic acid chloride (16F
) was added to a 1,2-dichloroethane solution (60 ml) of aluminum chloride (11y) and stirred at room temperature for 2 hours. Next, this reaction solution was cooled to 5°C, and 3.4.5
A solution of -trimethoxytoluene (7,49) in 1,2-dichloroethane (2 oml) is added and stirred at room temperature for 72 hours.
ついで本反応液を50°−60℃ に加熱し、30分間
かき混ぜる。放冷後メタノール200mnを加え、室温
で4時間かき混ぜる。溶媒を留去し、残留物をジクロル
メタンで抽出する。ジクロルメタン層は水洗し、無水硫
酸マグネシウムで乾燥後、溶媒を留去すると粗結晶が得
られる。ジクロルメタン−エーテル(1:1)から再結
晶すると、無色針状晶の6−(20−ヒドロキシ−1−
オキソエイコシル)−2、3−ジメトキシ−5−メチル
フェノール(11,4f/ )が得られる。融点105
℃
元素分析 C29H5006として
計算値 C,72,76:H,10,53実験値
0,72.95 :H,10,68IRシKBrCm”
:3500(OH)、3450(OH)。The reaction solution was then heated to 50°-60°C and stirred for 30 minutes. After cooling, add 200 ml of methanol and stir at room temperature for 4 hours. The solvent is distilled off and the residue is extracted with dichloromethane. The dichloromethane layer is washed with water, dried over anhydrous magnesium sulfate, and the solvent is distilled off to obtain crude crystals. Recrystallization from dichloromethane-ether (1:1) gives colorless needles of 6-(20-hydroxy-1-
Oxoeicosyl)-2,3-dimethoxy-5-methylphenol (11,4f/) is obtained. Melting point 105
°C Elemental analysis Calculated value as C29H5006 C,72,76:H,10,53 Experimental value
0,72.95:H,10,68IRshiKBrCm”
:3500(OH), 3450(OH).
aX
1670 (CO) 、 1610 、1580 (A
r)。aX 1670 (CO), 1610, 1580 (A
r).
NM几δCDCl5 :1.1−1.9[:34H=m
−−(CH2:bpm
−〕、2.42(3H,S、C6−0R1)、2.85
(2H,t 、J=7Hz 、C2−H2)、3.62
(2H。NM⇠δCDCl5:1.1-1.9[:34H=m
--(CH2:bpm −], 2.42 (3H, S, C6-0R1), 2.85
(2H,t, J=7Hz, C2-H2), 3.62
(2H.
t、J=6Hz、CH20H)+3.83(3H,S。t, J=6Hz, CH20H)+3.83(3H,S.
0CRs)、 3.88 (3H,s 、0CHx)、
6.25(IH,S、04−H)、10.07(IEl
、S、O。0CRs), 3.88 (3H,s, 0CHx),
6.25 (IH, S, 04-H), 10.07 (IEl
,S.O.
−0H)。-0H).
MSm/e : 478(M )、460.195
6−(20−ヒドロキシ−1−オキソエイコシル)−2
,3−ジメトキシ−5−メチルフェノール(4,1f)
(7)酢酸溶液(100m6)に5%パラジウム−炭素
(50%含水物) (、1(/ )と70%過塩素酸(
0,05m1)を加え、常温、常圧で接触還元する。水
素の吸収が終了したら触媒を濾別し、濾液を減圧下に濃
縮する。残留物に水を加えると粗結晶が析出する。本島
をエーテルから再結晶すると、無色針状晶の6−(20
−アセトキシ−エイコシル)−2,3−ジメトキシ−5
−メチルフェノール(4,2y)が得られる。融点59
℃
元素分析 cs+ H54o、。MSm/e: 478 (M), 460.195
6-(20-hydroxy-1-oxoeicosyl)-2
,3-dimethoxy-5-methylphenol (4,1f)
(7) In acetic acid solution (100 m6) 5% palladium-carbon (50% hydrated) (, 1 (/)) and 70% perchloric acid (
0.05 ml) was added and catalytic reduction was carried out at room temperature and pressure. After hydrogen absorption is completed, the catalyst is filtered off and the filtrate is concentrated under reduced pressure. When water is added to the residue, coarse crystals are precipitated. When the main island is recrystallized from ether, 6-(20
-acetoxy-eicosyl)-2,3-dimethoxy-5
-Methylphenol (4,2y) is obtained. Melting point 59
℃ Elemental analysis cs+ H54o,.
計算値 0.73.47 :H,10,74実験値
C,73,46;H,10,74IRシ翫:至Cm−
’: 3450 (OH)、1720 (OAc)。Calculated value 0.73.47:H,10,74 experimental value
C, 73, 46; H, 10, 74 IR wire: To Cm-
': 3450 (OH), 1720 (OAc).
1 61 0 、1 680 (Ar)。1 61 0, 1 680 (Ar).
NMICD” : 1.1−19 [34H,m、−
(OET2)、7pm
i、2.01 (3H,S 、0AC)、2.22 (
3H。NMICD”: 1.1-19 [34H,m,-
(OET2), 7pm i, 2.01 (3H,S,0AC), 2.22 (
3H.
S 、05−OHり12.55 (2H,t l J=
7Hz 。S, 05-OHri 12.55 (2H, t l J=
7Hz.
02−H2)、3.83 (3H,S 、0cH3)、
3.86(3H,S 、0CHx)、 4.02 (2
H,t 、0H20Ac)。02-H2), 3.83 (3H,S, 0cH3),
3.86 (3H, S, 0CHx), 4.02 (2
H,t,0H20Ac).
5.77(IH,S、C1−0H)、6.23(IH,
S。5.77 (IH, S, C1-0H), 6.23 (IH,
S.
C4−H)。C4-H).
MSm/e: 506(M )、464,446゜
181゜
本島を参考例1と同様に脱アセチル化すると6−(20
−ヒドロキシエイコシル)−2、3−ジメトキシ−5−
メチルフェノールが得られる。MSm/e: 506 (M ), 464,446° 181° When the main island is deacetylated in the same manner as in Reference Example 1, 6-(20
-hydroxyeicosyl)-2,3-dimethoxy-5-
Methylphenol is obtained.
上記の6−(20−ヒドロキシ−1−オキソエイコシル
)−2、3−ジメトキシ−5−メチルフェノール(2,
4y)の酢酸エチル溶液(150ml)に5%パラジウ
ム−炭素(50%含水物) (1,。The above 6-(20-hydroxy-1-oxoeicosyl)-2,3-dimethoxy-5-methylphenol (2,
4y) in ethyl acetate (150 ml) with 5% palladium-carbon (50% hydrate) (1,.
y)と70%過m素酸(o、o 5ml! ) ヲ加、
t、常温、50気圧で接触還元する。水素の吸収が終了
したら、触媒を濾別し、濾液を減圧下に濃縮すると粗結
晶が得られる。水晶をエーテルから再結晶すると無色針
状晶の6−(20−ヒドロキシエイコシル)−2、3−
ジメトキシ−5−メチルフェノール(2,21)が得ら
れる。融点72℃元素分析値 029H6204とし
て計算値 C,74,95:H,11,28実験値
0.75.19 :H,11,30IR,KBrcm
−+ :3450(OH)、3150(OH)。y) and 70% permonic acid (o, o 5ml!).
t, catalytic reduction at room temperature and 50 atm. After hydrogen absorption is completed, the catalyst is filtered off and the filtrate is concentrated under reduced pressure to obtain crude crystals. When crystals are recrystallized from ether, colorless needle-like crystals of 6-(20-hydroxyeicosyl)-2,3-
Dimethoxy-5-methylphenol (2,21) is obtained. Melting point 72℃ Elemental analysis value Calculated value as 029H6204 C,74,95:H,11,28 Experimental value
0.75.19:H, 11,30IR, KBrcm
-+: 3450 (OH), 3150 (OH).
ax 1610.1580(Ar)。ax 1610.1580 (Ar).
NMRδCD”s: 1.1−1.9 Cs s a、
m、−(cut)、8pm
−)、2.23(3H,s、C5−OH5)、2.54
(2H,t 、 J =7Hz 、 02−H2)、3
.61 (2H。NMRδCD”s: 1.1-1.9 Cs sa,
m, -(cut), 8pm -), 2.23 (3H, s, C5-OH5), 2.54
(2H, t, J = 7Hz, 02-H2), 3
.. 61 (2H.
t 、J=6Hz、0H20H)、 3.80(3H,
S 。t, J=6Hz, 0H20H), 3.80(3H,
S.
00Hx)、3.83(3H,s 、OOHg)、5.
80(IH,S、0l−OH)、6.25(IH,S、
04−■)。00Hx), 3.83 (3H,s, OOHg), 5.
80 (IH, S, 0l-OH), 6.25 (IH, S,
04-■).
MSm/e: 4G4(M )、446.181゜実
施例3
6−(20−ヒドロキシエイコシル)−2,3−シメト
キシー5−メチルフェノール(0,6f)のテトラこド
ロフラン溶液(80ml)に過硫酸カリウム(2,7(
1)の水溶液(20ml )を加え、室温、窒素気流下
に72時間かき混ぜる。生成物をエーテルですばやく抽
出し、エーテルを留去する。残留物である6−(20−
ヒドロキシエイコシル)−2,3−ジメトキシ−5−メ
チルヒドロキノンに無水酢酸1mlを加え3時間室温で
放置する。生成物は常法に従って抽出し、ヘキサンから
再結晶すると無色針状晶の6−(20−アセトキシエイ
コシル)−2,3−ジメトキシ−5−メチルヒドロキノ
ン−1,4−ジアセタート(0,31y)が得られる。MSm/e: 4G4 (M), 446.181° Example 3 A solution of 6-(20-hydroxyeicosyl)-2,3-simethoxy-5-methylphenol (0,6f) in tetrachodrofuran (80 ml) was added with a filter. Potassium sulfate (2,7(
Add the aqueous solution (20 ml) of 1) and stir at room temperature under a nitrogen stream for 72 hours. The product is quickly extracted with ether and the ether is distilled off. The residue 6-(20-
Add 1 ml of acetic anhydride to (hydroxyeicosyl)-2,3-dimethoxy-5-methylhydroquinone and let stand at room temperature for 3 hours. The product was extracted in a conventional manner and recrystallized from hexane to yield colorless needle-like crystals of 6-(20-acetoxyeicosyl)-2,3-dimethoxy-5-methylhydroquinone-1,4-diacetate (0,31y). is obtained.
融点67℃
元素分析 C! as H6a O8として計算値
0.69.50 :H,9,33実験値 0.69
.45 ;H,9,45■RvKBr −t 。Melting point 67℃ Elemental analysis C! Calculated value as H6a O8
0.69.50 :H,9,33 experimental value 0.69
.. 45;H,9,45■RvKBr-t.
maxCm 、1760(OAC)、1730(OA
c)。maxCm, 1760 (OAC), 1730 (OA
c).
NMRδCDC1’ : 1.1−1.8 C36H−
m、(CH2)u+pm
−)、2.01(3H,S、0AC)、2.03(3H
,S。NMRδCDC1': 1.1-1.8 C36H-
m, (CH2)u+pm -), 2.01 (3H, S, 0AC), 2.03 (3H
,S.
0a−C!Ha)、2.03(6H,s、0Acx2)
。0a-C! Ha), 2.03 (6H,s, 0Acx2)
.
2.2−2.6 (2H,m、O+−Ht)、3.79
(6H。2.2-2.6 (2H, m, O+-Ht), 3.79
(6H.
s 、OOHg X2 )、4.02 (2H,t 、
J=8Hz。s , OOHg X2 ), 4.02 (2H,t ,
J=8Hz.
CH20AC)。CH20AC).
M8m/e :60G(M )、564,522゜
462.197゜
参考例6
6−(20−アセトキシエイコシル)−2,3−ジメト
キシ−5−メチルヒドロキノン−1,4−ジアセタート
を参考例1の該当する工程にならい、メタノール性濃塩
酸で処理し、ついでメタノール性塩化第二鉄で処理する
と6−(20−ヒドロキシエイコシル)−2,3−ジメ
トキシ−5−メチル−1,4−ベンゾキノンが得られる
。M8m/e: 60G (M), 564,522° 462.197° Reference Example 6 6-(20-acetoxyeicosyl)-2,3-dimethoxy-5-methylhydroquinone-1,4-diacetate Reference Example 1 Following the corresponding step, treatment with methanolic concentrated hydrochloric acid and then with methanolic ferric chloride yields 6-(20-hydroxyeicosyl)-2,3-dimethoxy-5-methyl-1,4-benzoquinone. is obtained.
特許出願人 武田薬品工業株式会社Patent applicant: Takeda Pharmaceutical Company Limited
Claims (1)
、R_2、R_3、R_4は同一もしくは異なって水素
、低級アルキル基もしくは低級アシル基を示す) で表わされる化合物。[Claims] General formula ▲ Numerical formula, chemical formula, table, etc. or a lower acyl group).
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP63200334A JPH0193554A (en) | 1980-04-07 | 1988-08-10 | Organic compound |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP4593080A JPS56140943A (en) | 1980-04-07 | 1980-04-07 | Preparation of organic compound |
JP63200334A JPH0193554A (en) | 1980-04-07 | 1988-08-10 | Organic compound |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP4593080A Division JPS56140943A (en) | 1980-04-07 | 1980-04-07 | Preparation of organic compound |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH0193554A true JPH0193554A (en) | 1989-04-12 |
JPH0146498B2 JPH0146498B2 (en) | 1989-10-09 |
Family
ID=26386032
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP63200334A Granted JPH0193554A (en) | 1980-04-07 | 1988-08-10 | Organic compound |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH0193554A (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7432305B2 (en) | 2005-09-15 | 2008-10-07 | Edison Pharmaceuticals, Inc. | Tail variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers |
US9278085B2 (en) | 2006-02-22 | 2016-03-08 | Edison Pharmaceuticals, Inc. | Side-chain variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers |
US9399612B2 (en) | 2008-09-10 | 2016-07-26 | Edison Pharmaceuticals, Inc. | Treatment of pervasive developmental disorders with redox-active therapeutics |
US9447006B2 (en) | 2005-06-01 | 2016-09-20 | Edison Pharmaceuticals, Inc. | Redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers |
US10703701B2 (en) | 2015-12-17 | 2020-07-07 | Ptc Therapeutics, Inc. | Fluoroalkyl, fluoroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoquinone derivatives for treatment of oxidative stress disorders |
-
1988
- 1988-08-10 JP JP63200334A patent/JPH0193554A/en active Granted
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9447006B2 (en) | 2005-06-01 | 2016-09-20 | Edison Pharmaceuticals, Inc. | Redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers |
US11021424B2 (en) | 2005-06-01 | 2021-06-01 | Ptc Therapeutics, Inc. | Redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers |
US7432305B2 (en) | 2005-09-15 | 2008-10-07 | Edison Pharmaceuticals, Inc. | Tail variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers |
US9278085B2 (en) | 2006-02-22 | 2016-03-08 | Edison Pharmaceuticals, Inc. | Side-chain variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers |
US9932286B2 (en) | 2006-02-22 | 2018-04-03 | Bioelectron Technology Corporation | Side-chain variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers |
US9399612B2 (en) | 2008-09-10 | 2016-07-26 | Edison Pharmaceuticals, Inc. | Treatment of pervasive developmental disorders with redox-active therapeutics |
US10105325B2 (en) | 2008-09-10 | 2018-10-23 | Bioelectron Technology Corporation | Treatment of pervasive developmental disorders with redox-active therapeutics |
US10736857B2 (en) | 2008-09-10 | 2020-08-11 | Ptc Therapeutics, Inc. | Treatment of pervasive developmental disorders with redox-active therapeutics |
US10703701B2 (en) | 2015-12-17 | 2020-07-07 | Ptc Therapeutics, Inc. | Fluoroalkyl, fluoroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoquinone derivatives for treatment of oxidative stress disorders |
US10981855B2 (en) | 2015-12-17 | 2021-04-20 | Ptc Therapeutics, Inc. | Fluoroalkyl, fluoroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoquinone derivatives for treatment of oxidative stress disorders |
Also Published As
Publication number | Publication date |
---|---|
JPH0146498B2 (en) | 1989-10-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPS6365657B2 (en) | ||
MAY et al. | Structures Related to Morphine. XII. 1 (±)-2'-Hydroxy-5, 9-dimethyl-2-phenethyl-6, 7-benzomorphan (NIH 7519) and Its Optical Forms | |
JPH0133114B2 (en) | ||
JPH0193554A (en) | Organic compound | |
JPH0150688B2 (en) | ||
Carpino et al. | Benz [f] indene | |
Caine et al. | A convenient photochemical synthesis of a precursor to the spirovetivanes | |
FINDLAY et al. | THE SYNTHESIS OF CERTAIN SUBSTITUTED INDOLEACETIC ACIDS1 | |
Shive et al. | The Nitrogen Compounds in Petroleum Distillates. XXIII. The Structure of a C16H25N Base from California Petroleum1 | |
JPS61275266A (en) | Retinoid derivative | |
JPS6344733B2 (en) | ||
JP4310391B2 (en) | Method for producing tropolone compound | |
Lavie et al. | The Constituents of Ecballium elaterium L. VII. A Side Chain of Elatericin A and α-Elaterin1, 2 | |
Feuer et al. | Preparation and Reactions of α, α'-Dibromo-α, α'-dinitrocyclic Ketones1 | |
JPS6147450A (en) | O-allylphenyl ester derivative | |
JPH06100526A (en) | Phenoxyalkylcarboxylid acid derivative | |
Batu et al. | Synthesis of isotubaic acid (rotenic acid) | |
JPH06184007A (en) | Production of 2,3-dimethylnaphthalene | |
JPS61180734A (en) | Cyclopentane derivative | |
JPS6187639A (en) | Preparation of intermediate for synthesis of steroid | |
Pohl | The chemistry of benzocyclobutenedione | |
JPS60104039A (en) | Tricyclo(5.2.1.02,6)dec-3-ene-8,9-carboxylic acid diester and its production | |
JPS6011896B2 (en) | Method for producing quinone derivatives | |
JPH05170730A (en) | New intermediate compound and its production | |
JPH0641460B2 (en) | Method for producing α, β-epoxy aldehyde |